"Time","Event","Arm","Expression","Figure","Trial","Outcome","Units","Disease"
"0.907","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"0.99","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.25","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.61","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.85","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"3.73","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.14","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.58","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.89","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"9.15","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"9.53","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"10.3","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"12","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"17.4","1","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"0.396","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"0.8005","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"1.2","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"1.61","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.1","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.19","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.28","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.37","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.46","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.545","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.65","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.74","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.83","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.92","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.09","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.18","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.27","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.37","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.46","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.55","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.64","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.73","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.81","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.895","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"16.95","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"18.15","0","docetaxel","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"0.175","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"0.414","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"0.985","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"1.08","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"1.37","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"1.5","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"1.96","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.05","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.14","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.83","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"3.01","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.03","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"4.85","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.14","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"5.92","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.08","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.32","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.33","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.64","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.87","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"6.88","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"8.18","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"8.5","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"9.59","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"9.65","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"9.98","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"10.1","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"10.9","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"10.9","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"11","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"12","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"13.2","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"16.4","1","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"2.68","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"3.34","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"10.65","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"11.35","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"12.25","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"12.45","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"12.75","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"12.95","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"13.25","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"13.45","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"13.75","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"14.45","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"14.95","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"15.45","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"16.65","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"17.35","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"18.25","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
"18.55","0","atezolizumab","<1% pd-l1","3F","POPLAR","OS","Month","NSCLC"
